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The Etest MBL (AB BIODISK, Solna, Sweden) correctly differentiated all 57 isolates of Acinetobacter spp.
and Pseudomonas aeruginosa with the blaIMP-1 allele and 135 of 137 (98.5%) Acinetobacter spp. and Pseudomonas
spp. isolates with the blaVIM-2 allele. The Etest MBL was reliable for detecting the IMP-1- and VIM-2-
producing Pseudomonas and Acinetobacter isolates.
The IMP- and VIM-type and other acquired class B metallo-
-lactamase (MBL)-producing gram-negative bacilli have been
increasingly isolated from clinical specimens (10, 15). Among
the imipenem-nonsusceptible isolates, 62.1% of the 58 Pseudo-
monas aeruginosa isolates had a VIM-type MBL in a Greek
study (3), while 11.4% of 387 Pseudomonas spp. isolates and
14.2% of 267 Acinetobacter spp. isolates had either an IMP- or
VIM-type MBL in a Korean study (7).
MBL can hydrolyze -lactams from all classes except the
monobactams (1). Higher mortality has been reported in pa-
tients infected with the IMP-1-producing strains (5). There-
fore, the reliable detection of the MBL-producing strains is
essential for the optimal treatment of infected patients and to
control the nosocomial spread of resistance. However, the
current NCCLS document (12) does not contain any method
for detecting MBL.
MBL-producing strains can be detected with double-disk
synergy tests (8, 13) and a microdilution method (11). While
the former method is only qualitative, the latter is not simple
for routine testing. Walsh et al. (16) reported that the Etest
MBL strip (AB BIODISK, Solna, Sweden) had 100% sensitiv-
ity and specificity, but their findings were based on testing only
12 IMP-1-type strains and did not include the prevalent VIM-
2-type strains. The performance of Etest MBL was influenced
by the choice of the Mueller-Hinton agar brand (16) but may
have also been influenced by the level of imipenem resistance
of the MBL-producing strains (17, 18) and possibly by other
testing conditions.
In this study, the performance of Etest MBL was evaluated
with 199 blaVIM-2 or blaIMP-1 allele-positive isolates, and the
factors that may influence the routine use of the test were also
investigated.
(Part of this study was reported previously [A. Bolmstro¨m,
A. Engelhardt, P. Ho, Y. Chong, and K. Lee., Abstr. 42nd
Intersci. Conf. Antimicrob. Agents Chemother., abstr. D-532,
2002].)
Strains. The strains were isolated from the clinical speci-
mens at Korean hospitals between 1995 and 2003, and imi-
penem susceptibility was tested with the disk diffusion method
(12) using 10-g disks and Mueller-Hinton agar (Becton Dick-
inson, Cockeysville, Md.). MBL screening was tested with the
Hodge test and a double-disk synergy test (6, 8). The blaIMP-1
and blaVIM-2 alleles were detected by PCR (9). The isolates,
which were imipenem resistant but MBL negative by the
screening tests and PCR, were used as the negative controls.
The test strains were stored at 76°C until used for the study.
Evaluation of Etest MBL. The evaluations were performed
at two laboratories, one in Korea and the other in Sweden. The
Swedish laboratory used the strains that were transported in
semisolid cystine trypticase agar (Becton Dickinson) vials at
ambient temperature. Several colonies from a 24-h culture
plate were used to prepare the inoculum with a 0.5 McFarland
standard density. Mueller-Hinton agar plates (Becton Dickin-
son), the recommended medium (16), were streaked by using
cotton swabs (Korea) or a spiral inoculator (Sweden). The
Etest MBL strips were then applied, and the plates were in-
cubated at 35°C in air for 16 to 20 h. A ratio of the MICs of the
imipenem (IP) to IP plus EDTA (IPI) of8 or the presence of
a phantom zone, i.e., an extra inhibition zone between the IP
and IPI regions, or a deformation of the IP or IPI ellipses was
interpreted as being positive for MBL production. The sensi-
tivity and specificity of the Etest MBL were calculated based
on the recommendations by Elder et al. (2).
Performance of Etest MBL.The Etest MBL detected all 57
blaIMP-1 allele-positive isolates of Acinetobacter spp. and P.
aeruginosa and 140 of 142 (98.6%) blaVIM-2 allele-positive iso-
lates of Acinetobacter spp., Pseudomonas spp., and Enterobac-
teriaceae (Table 1). The test correctly differentiated 71 of the
73 (97.3%) imipenem-resistant but non-MBL-producing
isolates.
The Etest MBL strip was reported to be an acceptable di-
agnostic reagent for detecting the MBL-producing isolates
(16). The test was successfully used to screen the VIM-1-
producing Klebsiella pneumoniae strains for which imipenem
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MICs were 4 to 32 g/ml (4). In our study, one isolate of
Enterobacter cloacae for which the imipenem MIC was rela-
tively low (8 g/ml) was Etest MBL positive, but the test
became negative with a 10-fold reduction in the inoculum
(data not shown). Although an imipenem MIC of 0.5 g/ml
could be estimated on the IPI side, the strip needs to be
modified in order to detect the MBL-producing strains for
which the imipenem MICs were 4 g/ml (Fig. 1A).
Another important factor was found to influence the per-
formance of the Etest MBL. Some strains lost the blaIMP-1 or
blaVIM-2 genes partially or completely at ambient temperature:
29 MBL gene-positive isolates of P. aeruginosa and Acineto-
bacter spp. for which imipenem MICs were 16 to 256 g/ml at
the Korean laboratory gave negative Etest MBL results and
lower imipenem MICs (4 to 8 g/ml) at the Swedish labora-
tory (data not shown). Some of the strains showed imipenem
ellipses with either inner colonies (Fig. 1B) or a few resistant
colonies in the inhibition zone of the disk diffusion test (Fig.
1C). Retesting of these strains using fresh subcultures from
frozen stock gave the original higher imipenem MICs and
positive Etest MBL results (data not shown). Takahashi et al.
(14) observed a loss of blaIMP genes in 19 of 28 A. baumannii
isolates after storage in Casitone medium at room temperature
for a year or more and considered that the gene could be
retained only in the presence of imipenem. These results indi-
cate the importance of the simultaneous testing of phenotypic
MBL production and gene detection.
In conclusion, the Etest MBL is highly sensitive and specific
for detecting blaIMP-1 and blaVIM-2 allele-positive isolates of
Pseudomonas spp. and Acinetobacter spp. The strains kept at
ambient temperature may give negative results when the Etest
MBL is used due to the loss of MBL genes.
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